{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T03:51:00Z","timestamp":1793677860605,"version":"4.5.1"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100009619","name":"AMED","doi-asserted-by":"publisher","award":["JP19fm0108008"],"award-info":[{"award-number":["JP19fm0108008"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Aid for Scientific Research KAKENHI","award":["26462583"],"award-info":[{"award-number":["26462583"]}]},{"name":"Aid for Scientific Research KAKENHI","award":["15H04720"],"award-info":[{"award-number":["15H04720"]}]},{"DOI":"10.13039\/501100001691","name":"JSPS, Japan","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001700","name":"MEXT, Japan","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Antiviral Research"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1016\/j.antiviral.2019.104591","type":"journal-article","created":{"date-parts":[[2019,8,14]],"date-time":"2019-08-14T11:28:00Z","timestamp":1565782080000},"page":"104591","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["Efficacy of clarithromycin against H5N1 and H7N9 avian influenza a virus infection in cynomolgus monkeys"],"prefix":"10.1016","volume":"171","author":[{"given":"Masahiko","family":"Arikata","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasushi","family":"Itoh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shintaro","family":"Shichinohe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Misako","family":"Nakayama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirohito","family":"Ishigaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takaaki","family":"Kinoshita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mai Quynh","family":"Le","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshihiro","family":"Kawaoka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazumasa","family":"Ogasawara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Shimizu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.antiviral.2019.104591_bib1","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.antiviral.2009.05.003","article-title":"Macrolide antibiotics inhibit respiratory syncytial virus infection in human airway epithelial cells","volume":"83","author":"Asada","year":"2009","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2019.104591_bib2","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.resinv.2013.04.002","article-title":"Use of macrolides in the 2009 H1N1 virus infection outbreak: a survey of general practices in Japan","volume":"51","author":"Azuma","year":"2013","journal-title":"Respir. Investig."},{"key":"10.1016\/j.antiviral.2019.104591_bib3","doi-asserted-by":"crossref","first-page":"159","DOI":"10.3855\/jidc.18","article-title":"Macrolides for the treatment of severe respiratory illness caused by novel H1N1 swine influenza viral strains","volume":"3","author":"Bermejo-Martin","year":"2009","journal-title":"J. Infect. Dev. Ctries."},{"key":"10.1016\/j.antiviral.2019.104591_bib4","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1001\/jama.2009.294","article-title":"Infections with oseltamivir-resistant influenza A(H1N1) virus in the United States","volume":"301","author":"Dharan","year":"2009","journal-title":"J. Am. Med. Assoc."},{"key":"10.1016\/j.antiviral.2019.104591_bib5","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1056\/NEJMoa1304459","article-title":"Human infection with a novel avian-origin influenza A (H7N9) virus","volume":"368","author":"Gao","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.antiviral.2019.104591_bib6","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1086\/529439","article-title":"Effect of clarithromycin in patients with sepsis and ventilator-associated pneumonia","volume":"46","author":"Giamarellos-Bourboulis","year":"2008","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.antiviral.2019.104591_bib7","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.bbrc.2013.05.112","article-title":"Influenza virus utilizes N-linked sialoglycans as receptors in A549 cells","volume":"436","author":"Hidari","year":"2013","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.antiviral.2019.104591_bib8","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.resinv.2014.05.001","article-title":"Additional treatment with clarithromycin reduces fever duration in patients with influenza","volume":"52","author":"Higashi","year":"2014","journal-title":"Respir. Investig."},{"key":"10.1016\/j.antiviral.2019.104591_bib9","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1016\/j.chest.2016.11.012","article-title":"Efficacy of clarithromycin-naproxen-oseltamivir combination in the treatment of patients hospitalized for influenza A(H3N2) infection: an open-label randomized, controlled, phase IIb\/III trial","volume":"151","author":"Hung","year":"2017","journal-title":"Chest"},{"key":"10.1016\/j.antiviral.2019.104591_bib10","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.jinf.2011.12.002","article-title":"Clarithromycin has limited effects in non-elderly, non-severe patients with seasonal influenza virus A infection","volume":"64","author":"Ishii","year":"2012","journal-title":"J. Infect."},{"key":"10.1016\/j.antiviral.2019.104591_bib11","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1004192","article-title":"Protective efficacy of passive immunization with monoclonal antibodies in animal models of H5N1 highly pathogenic avian influenza virus infection","volume":"10","author":"Itoh","year":"2014","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.antiviral.2019.104591_bib12","doi-asserted-by":"crossref","first-page":"4962","DOI":"10.1128\/AAC.00793-15","article-title":"Emergence of H7N9 influenza A virus resistant to neuraminidase inhibitors in nonhuman primates","volume":"59","author":"Itoh","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2019.104591_bib13","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/j.chom.2017.09.008","article-title":"A highly pathogenic avian H7N9 influenza virus isolated from A human is lethal in some Ferrets infected via respiratory droplets","volume":"22","author":"Imai","year":"2017","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.antiviral.2019.104591_bib14","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/S0140-6736(05)78360-4","article-title":"Long-term azithromycin may improve lung function in children with cystic fibrosis","volume":"351","author":"Jaffe","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.antiviral.2019.104591_bib15","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0091293","article-title":"Efficacy of combination therapy with oseltamivir phosphate and azithromycin for influenza: a multicenter, open-label, randomized study","volume":"9","author":"Kakeya","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.antiviral.2019.104591_bib16","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1128\/CMR.00078-09","article-title":"Mechanisms of action and clinical application of macrolides as immunomodulatory medications","volume":"23","author":"Kanoh","year":"2010","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.antiviral.2019.104591_bib17","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/S0140-6736(04)16934-1","article-title":"Resistant influenza A viruses in children treated with oseltamivir: descriptive study","volume":"364","author":"Kiso","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.antiviral.2019.104591_bib18","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1001079","article-title":"Characterization of oseltamivir-resistant 2009 H1N1 pandemic influenza A viruses","volume":"6","author":"Kiso","year":"2010","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.antiviral.2019.104591_bib19","doi-asserted-by":"crossref","first-page":"4795","DOI":"10.1128\/AAC.02817-14","article-title":"Efficacy of repeated intravenous administration of peramivir against highly pathogenic avian influenza A (H5N1) virus in cynomolgus macaques","volume":"58","author":"Kitano","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2019.104591_bib20","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1164\/ajrccm.157.6.9710075","article-title":"Improvement of survival in patients with diffuse panbronchiolitis treated with low-dose erythromycin","volume":"157","author":"Kudoh","year":"1998","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.antiviral.2019.104591_bib21","doi-asserted-by":"crossref","first-page":"2485","DOI":"10.1099\/vir.0.021659-0","article-title":"Pathogenicity of highly pathogenic avian H5N1 influenza A viruses isolated from humans between 2003 and 2008 in northern Vietnam","volume":"91","author":"Le","year":"2010","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.antiviral.2019.104591_bib22","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.1007\/s00705-018-3852-4","article-title":"Triple combination of FDA-approved drugs including flufenamic acid, clarithromycin and zanamivir improves survival of severe influenza in mice","volume":"163","author":"Lee","year":"2018","journal-title":"Arch. Virol."},{"key":"10.1016\/j.antiviral.2019.104591_bib23","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.antiviral.2017.05.008","article-title":"Anti-inflammatory effects of adjunctive macrolide treatment in adults hospitalized with influenza: a randomized controlled trial","volume":"144","author":"Lee","year":"2017","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2019.104591_bib24","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1007\/s00134-013-2829-8","article-title":"Macrolide-based regimens in absence of bacterial co-infection in critically ill H1N1 patients with primary viral pneumonia","volume":"39","author":"Martin-Loeches","year":"2013","journal-title":"Intensive Care Med."},{"key":"10.1016\/j.antiviral.2019.104591_bib25","doi-asserted-by":"crossref","first-page":"8981","DOI":"10.1128\/JVI.00907-14","article-title":"Disease severity is associated with differential gene expression at the early and late phases of infection in non-human primates infected with different H5N1 highly pathogenic avian influenza viruses","volume":"88","author":"Muramoto","year":"2014","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2019.104591_bib26","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0082740","article-title":"Protection against H5N1 highly pathogenic avian and pandemic (H1N1) 2009 influenza virus infection in cynomolgus monkeys by an inactivated H5N1 whole particle vaccine","volume":"8","author":"Nakayama","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.antiviral.2019.104591_bib27","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1272\/jnms.69.53","article-title":"Effect of macrolides on duration and resolution of symptoms and complication of pneumonia in children with influenza","volume":"69","author":"Ninomiya","year":"2002","journal-title":"J. Nippon Med. Sch."},{"key":"10.1016\/j.antiviral.2019.104591_bib28","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1128\/AAC.01608-09","article-title":"Detection of E119V and E119I mutations in influenza A (H3N2) viruses isolated from an immunocompromised patient: challenges in diagnosis of oseltamivir resistance","volume":"54","author":"Okomo-Adhiambo","year":"2010","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2019.104591_bib29","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1183\/09031936.00054108","article-title":"Impact of macrolide therapy on mortality for patients with severe sepsis due to pneumonia","volume":"33","author":"Restrepo","year":"2009","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.antiviral.2019.104591_bib30","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1097\/01.CCM.0000266755.75844.05","article-title":"Combination antibiotic therapy improves survival in patients with community-acquired pneumonia and shock","volume":"35","author":"Rodr\u00edguez","year":"2007","journal-title":"Crit. Care Med."},{"key":"10.1016\/j.antiviral.2019.104591_bib31","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1164\/ajrccm.157.3.9703098","article-title":"Therapeutic effect of erythromycin on influenza virus-induced lung injury in mice","volume":"157","author":"Sato","year":"1998","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.antiviral.2019.104591_bib32","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1111\/j.1440-1843.2009.01639.x","article-title":"Boost of mucosal secretory immunoglobulin A response by clarithromycin in paediatric influenza","volume":"14","author":"Sawabuchi","year":"2009","journal-title":"Respirology"},{"key":"10.1016\/j.antiviral.2019.104591_bib33","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.virol.2016.03.007","article-title":"Comparison of pathogenicities of H7 avian influenza viruses via intranasal and conjunctival inoculation in cynomolgus macaques","volume":"493","author":"Shichinohe","year":"2016","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2019.104591_bib34","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1164\/rccm.200212-1437OC","article-title":"In vivo and in vitro effects of macrolide antibiotics on mucus secretion in airway epithelial cells","volume":"168","author":"Shimizu","year":"2013","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.antiviral.2019.104591_bib35","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.anl.2015.08.014","article-title":"Past, present and future of macrolide therapy for chronic rhinosinusitis in Japan","volume":"43","author":"Shimizu","year":"2016","journal-title":"Auris Nasus Larynx"},{"key":"10.1016\/j.antiviral.2019.104591_bib36","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0070060","article-title":"Immunomodulator clarithromycin enhances mucosal and systemic immune responses and reduces re-infection rate in pediatric patients with influenza treated with antiviral neuraminidase inhibitors: a retrospective analysis","volume":"8","author":"Shinahara","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.antiviral.2019.104591_bib37","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1164\/ajrccm.165.8.2103094","article-title":"Erythromycin inhibits rhinovirus infection in cultured human tracheal epithelial cells","volume":"165","author":"Suzuki","year":"2001","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.antiviral.2019.104591_bib38","doi-asserted-by":"crossref","first-page":"10924","DOI":"10.1128\/JVI.01207-12","volume":"86","author":"Takahashi","year":"2012","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2019.104591_bib39","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1111\/irv.12132","article-title":"Characterization of neuraminidase inhibitor-resistant influenza A(H1N1) pdm09 viruses isolated in four seasons during pandemic and post-pandemic periods in Japan","volume":"7","author":"Takashita","year":"2013","journal-title":"Influenza Other Respir. Viruses."},{"key":"10.1016\/j.antiviral.2019.104591_bib40","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1093\/cid\/ciq183","article-title":"Frequency of drug-resistant viruses and virus shedding in pediatric influenza patients treated with neuraminidase inhibitors","volume":"52","author":"Tamura","year":"2011","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.antiviral.2019.104591_bib41","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1038\/nature12392","article-title":"Characterization of H7N9 influenza A viruses isolated from humans","volume":"501","author":"Watanabe","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.antiviral.2019.104591_bib42","unstructured":"World Health Organization. Influenza at the human-animal interface. Available from:: https:\/\/www.who.int\/influenza\/human_animal_interface\/Influenza_Summary_IRA_HA_interface_02_03_2018.pdf?ua=1."},{"key":"10.1016\/j.antiviral.2019.104591_bib43","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1124\/jpet.109.162149","article-title":"Clarithromycin inhibits type a seasonal influenza virus infection in human airway epithelial cells","volume":"333","author":"Yamaya","year":"2010","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.antiviral.2019.104591_bib44","article-title":"Genesis and spread of newly emerged highly pathogenic H7N9 avian viruses in mainland China","volume":"61","author":"Yang","year":"2017","journal-title":"J. Virol."}],"container-title":["Antiviral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354219301147?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354219301147?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T12:29:08Z","timestamp":1759062548000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166354219301147"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11]]},"references-count":44,"alternative-id":["S0166354219301147"],"URL":"https:\/\/doi.org\/10.1016\/j.antiviral.2019.104591","relation":{},"ISSN":["0166-3542"],"issn-type":[{"value":"0166-3542","type":"print"}],"subject":[],"published":{"date-parts":[[2019,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy of clarithromycin against H5N1 and H7N9 avian influenza a virus infection in cynomolgus monkeys","name":"articletitle","label":"Article Title"},{"value":"Antiviral Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.antiviral.2019.104591","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"104591"}}